НовостиBenzingaBTIG Maintains Buy on Bicara Therapeutics, Lowers Price Target to $37 BTIG Maintains Buy on Bicara Therapeutics, Lowers Price Target to $37 Benzinga 2026.11.10 08:32 (GMT+0) Открыть на Benzinga Другие новости